Gelonghui November 1st | Beijing Leadman Biochemistry (300289.SZ) stated on the investor interaction platform that the patented application scenarios of the microfluidic fluorescence immunoassay chip technology obtained by the company are in the field of immunological analysis in clinical testing.
利德曼(300289.SZ)：微流控荧光免疫芯片技术专利应用场景为临床检验的免疫分析领域
Beijing Leadman Biochemistry (300289.SZ): The patented application scenarios of microfluidic fluorescence immunoassay chip technology are in the field of clinical immunological analysis.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated